Myovant Sciences Ltd. Quarterly Deferred Tax Assets, Gross in USD from Q1 2016 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Myovant Sciences Ltd. quarterly Deferred Tax Assets, Gross history and growth rate from Q1 2016 to Q1 2022.
  • Myovant Sciences Ltd. Deferred Tax Assets, Gross for the quarter ending March 31, 2022 was $246M, a 17.1% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2022 $246M +$35.9M +17.1% Mar 31, 2022 10-K 2022-05-11
Q1 2021 $211M +$50.3M +31.4% Mar 31, 2021 10-K 2022-05-11
Q1 2020 $160M +$67.5M +72.8% Mar 31, 2020 10-K 2021-05-11
Q1 2019 $92.7M +$71.2M +330% Mar 31, 2019 10-K 2020-05-18
Q1 2018 $21.5M +$13.7M +174% Mar 31, 2018 10-K 2019-05-24
Q1 2017 $7.86M +$7.86M Mar 31, 2017 10-K 2018-06-07
Q1 2016 $0 Mar 31, 2016 10-K 2017-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.